Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18681)

• Formulation Name: Raloxifene 60 mg tablet
• Company: Aphena Pharma Solutions-Tennessee; Aurobindo Pharma; Kaiser Foundation Hospitals; Lucid Pharma; Prasco

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Raloxifene	(DMDKF3M)	Osteoporosis	FB83.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Citric acid monohydrate	(E00271)	22230	Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
Crospovidone	(E00626)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 400	(E00653)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Vinylpyrrolidone	(E00668)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent